AstraZeneca s UK vaccine trial on kids comes to a halt
By IANS |
7 Views
Photo taken on March 12, 2021 shows AstraZeneca/Oxford vaccines at a hospital in Caceres province in Spain. (Photo by Gustavo Valiente/Xinhua/IANS). Image Source: IANS News
London, April 7 : A trial of the Oxford-AstraZeneca Covid-19 vaccine on children in the UK has been paused even as the country s medicines regulator probes a possible link of the vaccine with rare blood clots in adults, the media reported.
The trial, which started in February, is evaluating whether the vaccine generates a strong immune response in those aged between 6 and 17.
While the trial has been paused, Professor Andrew Pollard from the University of Oxford ruled out safety concerns with the trial itself, the BBC reported on Wednesday.
Australia will continue to roll out the AstraZeneca Covid vaccine despite health officials admitting they do not know if it causes potentially deadly blood clots.
In March more than a dozen countries suspended the jab after a handful of European patients suffered brain blockages that can cause strokes.
Germany is still banning the vaccine for under 60s amid fears the clots are more prominent in young people, particularly young women.
In March more than a dozen countries suspended the AstraZeneca jab after a handful of European patients suffered brain blockages that can cause strokes
European regulators are reviewing the data and on Tuesday Marco Cavaleri, head of vaccines at the European Medicines Agency, said he believes there is a causal link between the vaccine and the clots.
UK: Trial Of AstraZeneca Covid-19 Vaccine On Children Paused As British Medicines Regulator Probes Blood Clot Link
by IANS - Apr 7, 2021 10:08 AM AstraZeneca
A trial of the Oxford-AstraZeneca Covid-19 vaccine on children in the UK has been paused even as the country s medicines regulator probes a possible link of the vaccine with rare blood clots in adults, the media reported.
The trial, which started in February, is evaluating whether the vaccine generates a strong immune response in those aged between 6 and 17.
While the trial has been paused, Professor Andrew Pollard from the University of Oxford ruled out safety concerns with the trial itself, the BBC reported on Wednesday (7 April).
UK begins rollout of Moderna jab
By IANS |
8 Views
Photo taken on March 12, 2021 shows AstraZeneca/Oxford vaccines at a hospital in Caceres province in Spain. (Photo by Gustavo Valiente/Xinhua/IANS). Image Source: IANS News
London, April 7 : Amid the concerns over the potential link between the AstraZeneca jab and rare blood clots, the UK on Wednesday rolled out a third Covid-19 vaccine developed by the US-based Biotechnology company Moderna.
The Moderna vaccine follows the Pfizer-BioNTech and Oxford-AstraZeneca jabs, which are already widely in use, the BBC reported.
The government said it has ordered seventeen million doses, which will be the third to be administered in the UK since the rollout began in December last year.
YVES HERMAN
REUTERS
A trial of the Oxford-AstraZeneca covid-19 vaccine in children has been halted while the UK’s drug regulator, The Medicines and Healthcare products Regulatory Agency (MHRA), investigates
potential links between the vaccine and thrombosis in adults. The trial, on 300 volunteers between the ages of six and 17 put forward with parental approval, started in February with the aim of
determining whether the AstraZeneca vaccine produces a strong immune response in children in that age group.
The pausing of the UK-based trial comes amid
global concern that the AstraZeneca vaccine can cause rare blood clotting in adults. A European Medicines Agency (EMA) official, apparently speaking in an official capacity, said there appeared to be a link between the vaccine and cases of clotting in adults.